Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Revenue

Artgen Biotech PJSC had revenue of 877.30M RUB in the half year ending December 31, 2025, with 17.37% growth. This brings the company's revenue in the last twelve months to 1.76B, up 8.74% year-over-year. In the year 2025, Artgen Biotech PJSC had annual revenue of 1.72B with 12.80% growth.

• Revenue (ttm): 1.76B
• Revenue Growth: +8.74%
• P/S Ratio: 2.44
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.29B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.72B	194.69M	12.80%
Dec 31, 2024	1.52B	152.94M	11.18%
Dec 31, 2023	1.37B	231.65M	20.38%
Dec 31, 2022	1.14B	-43.89M	-3.72%
Dec 31, 2021	1.18B	96.77M	8.93%

Data Source: S&P Global Market Intelligence Last updated: Apr 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error